Normative State and Variation in Growth, Hematology, Hydration, Oxidation, Infection, Inflammation, Guatemalan Children

Sponsor
María José Soto (Other)
Overall Status
Completed
CT.gov ID
NCT02203890
Collaborator
Universidad de Granada (Other)
91
1
5
18.1

Study Details

Study Description

Brief Summary

This study will provide the researchers with an opportunity for the investigation of the biomarkers and different human biology component variable interactions in children; information that can generate new correlations between markers not known at the moment.

Regarding their analysis, variation could have multiple connotations. A categorical that refers to a specific state, established with a diagnostic standard. And a numerical, referring to a range or the absolute value limits in a continuous spectrum; this research will allow us to express variability in the distance amplitude of the obtained values level, as well as classifications or categories previously established in the possible cases.

OBJECTIVES PRINCIPAL OBJECTIVE

To estimate the inter and intra-individual variety in a selected series or biological variables determinant of growth, body composition, infection, oxidation, inflammation and hydration, in preschool children sharing the same institutional-based diet.

SPECIFIC OBJECTIVES

  • To determine the inter and intra-individual variation of growth in preschool children, with a similar diet, who attend Secretariat of Beneficial Works of the First Lady system daycare centers and to compare between semi-urban and rural.

  • To describe the inter-individual variation of the red blood cells circulating mass in preschool children, with a similar diet, who attend day care centers and to compare between semi-urban and rural.

  • To determine the inter-individual variation of systemic and intraintestinal oxidation in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.

  • To describe the inter-individual variation of systemic and intraintestinal inflammation in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.

  • To determine the inter and/or intra-individual variation of urinary tract infection and gastrointestinal parasite infestation in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.

  • To describe the inter and intra-individual variation of the hydration status in preschool children, with a similar diet, who attend daycare centers and to compare between semi-urban and rural.

  • To explore intra-individual associations in variables of the same research component or different component variables.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Please note protocol is also available in Spanish.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    91 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Study on the Normative State and Inter- and Intra-individual Variation in Growth, Hematology, Hydration and Markers of Oxidation, Infection and Inflammation in Preschool Children With a Similar Dietary Intake
    Study Start Date :
    Jun 1, 2012
    Actual Primary Completion Date :
    Nov 1, 2012
    Actual Study Completion Date :
    Nov 1, 2012

    Arms and Interventions

    Arm Intervention/Treatment
    Apparently Healthy

    Apparently healthy preschool children who attend 3 daycare centers of the Secretariat of Beneficials Works of the First Lady in Guatemalan Western Highlands

    Outcome Measures

    Primary Outcome Measures

    1. Weight [7th week of observation]

      Growth, measured trough weight (kg)

    2. Hemoglobin [8th week of observation]

      Hemoglobin (mg/dl) measured in Biochemistry Laboratory in La Democracia Hospital, Quetzaltenango, Guatemala.

    3. Urine Osmolality-1 [6th week of observation]

      Hydration Status= measured in 24-h urine through urine volume and osmolality in osmometer Model Löser 815. Results in mOsm/kg.

    4. Height [7th week of observation]

      Growth, measured trough height (cm).

    5. Urine Osmolality-2 [7th week of observation]

      Hydration Status= measured in 24-h urine through urine volume and osmolality Osmometer Model Löser 815. Results in mOsm/kg.

    6. Urine Osmolality-3 [8th week of observation]

      Hydration Status= measured in 24-h urine through urine volume and osmolality in two different osmometers (Löser 815 and Osmomat 030). Results in mOsm/kg.

    7. Urine Urea [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: urea (mg/l)

    8. Urine Uric Acid [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: uric acid (mg/l)

    9. Urine Sodium [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: sodium (mg/l)

    10. Urine Potassium [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: potassium (mg/l)

    11. Urine Calcium [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: calcium (mg/l)

    12. Urine Magnesium [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: magnesium (mg/l)

    13. Urine Phosphorus [8th week of oservation]

      Urine solutes measured by the Scientific Instrumentation Center from the Granada University, Spain: inorganic phosphorus (mg/l)

    14. Urine 15-f2t-Isoprostanes [8th week of observation]

      Urine Oxidation biomarkers: 15-f2t-Isoprostanes (ng/mL) Measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada using ELISA assay kit (Oxford Biomedical Research, Inc., Catalog # EA84.102606, Michigan, USA)

    15. Urine 8-Hydroxydeoxyguanosine [8th week of observation]

      Urine Oxidation biomarkers: 8-Hydroxydeoxyguanosine (ng/mL) Measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada using ELISA assay kits (JaICA, Nikken SEIL Co., Ltd, Catalog# IM-KOGHS 040914E, Shizouka, Japan).

    16. Catalase Activity [8th week of observation]

      Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system: Catalase Activity (nmol/seg/g Hb)

    17. Superoxide Dismutase Activity [8th week of observation]

      Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system Superoxide Dismutase Activity (U/g Hb)

    18. Gluthathione Reductase [8th week of observation]

      Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system Gluthathione Reductase Activity (umol/min/g Hb)

    19. Gluthathione Peroxidase [8th week of observation]

      Activity of antioxidant enzymes in red blood cells; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using ELISA system Gluthathione Peroxidase Activity (uU/g Hb)

    20. Retinol [8th week of observation]

      Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada. Retinol (mg/dl)

    21. Alpha-tocopherol [8th week of observation]

      Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada. Alpha-tocopherol (mg/l)

    22. Beta-Carotenes [8th week of observation]

      Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada. Beta-carotenes (mg/l)

    23. Coenzyme Q9 [8th week of observation]

      Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada. Coenzyme Q9 (mg/l)

    24. Coenzyme Q10 [8th week of observation]

      Content of antioxidant compounds in plasma; Scientific Instrumentation Center, University of Granada. Coenzyme Q10 (mg/l)

    25. Plasma Interleukin-1B [8th week of observation]

      Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Plasma IL-1B (pg/ml)

    26. Plasma Interleukin-6 [8th week of observation]

      Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Plasma IL-6 (pg/ml)

    27. Plasma Interleukin-8 [8th week of observation]

      Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Plasma IL-8 (pg/ml)

    28. Plasma Interleukin-10 [8th week of observation]

      Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Plasma IL-10 (pg/ml)

    29. Plasma Tumor Necrosis Factor-Alpha [8th week of observation]

      Plasma Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Plasma Tumor Necrosis Factor-Alpha (pg/ml)

    30. Saliva Interleukin-1B [8th week of observation]

      Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva IL-1B (pg/ml)

    31. Saliva Interleukin-6 [8th week of observation]

      Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva IL-6 (pg/ml)

    32. Saliva Interleukin-8 [8th week of observation]

      Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva IL-8 (pg/ml)

    33. Saliva Interleukin-10 [8th week of observation]

      Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system Saliva IL-10 (pg/ml)

    34. Saliva Tumor Necrosis Factor-Alpha [8th week of observation]

      Saliva Interleukines; measured at the Institute of Nutrition and Food Technology, Center of Biomedical Research, University of Granada, using the Luminex system: Saliva Tumor Necrosis Factor-Alpha (pg/ml)

    35. Fecal Calprotectin [8th week of observation]

      Fecal Calprotectin (mg/kg) measured using the ELISA assay kit from Calpro-Lab (Catalog # CAL0100).

    36. Intestinal Parasitosis [8th week of observation]

      Intestinal Parasitosis, measured by Biochemistry Laboratory, La Democracia Hospital, Quetzaltenango, Guatemala. Parasite cysts presence in feces.

    37. Giardiasis Infection Presence-1 [7th week of observation]

      Analyses done by ELISA assay kit (ProSpecT Giardia EZ, catalog #R2458596), absorbance (O.D)

    38. Giardiasis Infection Presence-2 [8th week of observation]

      Analyses done by ELISA assay kit (ProSpecT Giardia EZ, catalog #R2458596), absorbance (O.D)

    39. White Urine Cell Count [8th week of observation]

      White urine cell count (per field), to be determined in Biochemistry Laboratory in La Democracia Hospital, Quetzaltenango Guatemala.

    40. White Blood Cell Count [8th week of observation]

      White blood cell count (cells/ul), to be determined in Biochemistry Laboratory in La Democracia Hospital, Quetzaltenango Guatemala.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    23 Months to 84 Months
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • To be attending one of the SOSEP systems assigned daycare centers

    • To maintain an attendance of 80% during the 8 weeks of the fieldwork

    • Aged 23 to 84 months

    • Being apparently healthy and with no dietary restrictions related to the foods offered with the SOSEP menu.

    Exclusion Criteria:
    • Children whose parents of caregivers did not sign a consent form

    • Children who refused to participate in the study

    • Children who refused to adhere to the collections routines.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Center for Studies of Sensory Impairment Aging and Metabolism Guatemala Quetzaltenango Guatemala 09001

    Sponsors and Collaborators

    • María José Soto
    • Universidad de Granada

    Investigators

    • Principal Investigator: Maria J. Soto-Méndez, MSc, Center for Studies of Sensory Impairment, Aging and Metabolism

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    María José Soto, PhD student and nutrition researcher, Center for Studies of Sensory Impairment, Aging and Metabolism
    ClinicalTrials.gov Identifier:
    NCT02203890
    Other Study ID Numbers:
    • CeSSIAM_02
    First Posted:
    Jul 30, 2014
    Last Update Posted:
    Jul 30, 2014
    Last Verified:
    Jul 1, 2014
    Keywords provided by María José Soto, PhD student and nutrition researcher, Center for Studies of Sensory Impairment, Aging and Metabolism
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 30, 2014